Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L929 |
Mouse subcutaneous connective tissue fibroblast cell line | ATCC CCL-1 | Mouse | other | cell line | adherent | plasmid | Metafectene PRO | publication | K. G. Frey et al., J. Immunol., Jul 2009; 183: 1253 - 1262 | Link | ||
L8 |
Rat myoblast cell line | ATCC CRL-1769 | Rat | muscle | cell line | adherent | plasmid | Metafectene | publication | P. Orth et al., Mol Biotechnol, Feb 2008; 38(2): 137-44 | |||
L6 |
Rat myoblast cell line | ATCC CRL-1458 | Rat | muscle | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
L3.6pl |
Human pancreatic adenocarcinoma cell line | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | H. Seeliger et al., Mol. Cancer Res., Feb 2009; 7: 189 - 198 | Link | |||
L-02 |
Human fetal hepatocyte cell line | Human | digestive organs | cell line | siRNA | RNA-Interference | Metafectene | publication | R. Liu et al., Tumor Biology, April 2017: 1 -13, doi.org/10.1177/1010428317695031 | Link | |||
L cells |
Mouse subcutaneous connective tissue fibroblast cell line | ATCC CRL-2648 | Mouse | other | cell line | adherent | plasmid | stable transfection | Metafectene | publication | V. J. Jokubaitis et al., Blood, Apr 2008; 111: 4055 - 4063 | Link | |
KMST-6 |
Human immoralized fibroblasts | Human | unknown | cell line | adherent | plasmid | Metafectene PRO | publication | S. Kanyanda, Dissertation, 2012, University of the Western Cape | Link | |||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | T. Sugawara et al., J. Biol. Chem., Oct 2003; 278: 42487 - 42494 | Link | ||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | L. Bouazzi et al., J. Gyneco.l Reprod. Med., 2018, 2(1):1-9 | Link | |||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C. Wang et al., Am. .J Transl. Res., 2012, 4 (4): 390-402 | Link | ||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Fu et al., Endocr. Relat. Cancer, Mar 2014; 21: 297 - 310 | Link | ||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | L. Bouazzi et al., Scientific Reports, 2019, 9: 17033, doi.org/10.1038/s41598-019-53370-4 | Link | |||
KGN |
Human ovary granulosa-like tumor cell line | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | M. Lang-Muritano et al., J. of Clinical Endocrinology & Metabolism, 2018, 103(10): 3748–3756 | ||||
KG1 |
Human myelogenous leukemia cell line | ATCC CRL-8031 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | B. Landry et al., PLoS ONE, 2012, 7(8): e44197, doi:10.1371/journal.pone.0044197 | Link | |
KG1 |
Human myelogenous leukemia cell line | ATCC CRL-8031 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | application note | ![]() |
|||
KB |
Human cancer cell line (Hela contaminant) | ATCC CCL-17 | Human | unknown | cell line | adherent | plasmid | Metafectene | publication | K. Konopka et al., Cell Mol Biol Lett, Jan 2009; 14(1): 70-89 | |||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | E. Kowenz-Leutz et al., EMBO J., Mar 2010; 29: 1105 - 1115 | Link | ||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | publication | N. Courtial et al., PLoS ONE, 2013, 8(9): e76637. doi:10.1371/journal.pone.0076637 | Link | ||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | O. N. Kuvardina et al., Oncotarget, 2017, 8 (42): 71685-71698 | Link | |
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | A. Meyer, Dissertation, 2020, Universität Stuttgart | Link | ||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 | |||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | C. Rosner et al., J. Immunol., Feb 2011; 186: 2156 - 2163 | Link | ||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | O. N. Kuvardina et al., Oncotarget, 2017, 8 (42): 71685-71698 | Link | ||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | M. Merkerova et al., Mol Biol Rep, Mar 2007; 34(1): 27-33 | ||
K562 |
Human myelogenous leukemia cell line | ATCC CCL-243 | Human | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | N. Sahner, Dissertation, 2019, Technische Universität Darmstadt | Link |